§ Funding Round
Series A funding round for Glyscend Therapeutics raising $20M in June 2020
Series A funding round for Glyscend Therapeutics raising $20M in June 2020
This company has completed 1 funding round. Current round is highlighted.
Total Raised
$20M
Top Valuation
-
Glyscend Therapeutics raised $20M in a Series A round.
The round was announced on 06/01/20.
The round was led by Santé Ventures, bob soh.
